David has made over 1 trades of the Boston Scientific stock since 2006, according to the Form 4 filled with the SEC. Most recently he bought 55,000 units of BSX stock worth $959,200 on 16 February 2006.
The largest trade he's ever made was buying 55,000 units of Boston Scientific stock on 16 February 2006 worth over $959,200. On average, David trades about 2,895 units every 0 days since 2005. As of 16 February 2006 he still owns at least 56,706 units of Boston Scientific stock.
You can see the complete history of Mr. Roux stock trades at the bottom of the page.
David J. Roux Ph.D. serves as Independent Director of the Company. Mr. Roux is Chairman of Jackson Laboratories, an independent biomedical research institute. He is the co-founder and was the Chairman, co-Chief Executive Officer and managing partner of Silver Lake, a private equity firm focused on technology investing, from January 2014 to December 2017. Prior to that, Mr. Roux was Chairman and Chief Executive Officer of Liberate Technologies, Executive Vice President at Oracle Corporation and Senior Vice President at Lotus Development. He is also Chairman of Bristol Seafoods and Vice Chairman of National Audubon Society. He previously served as a director of Avaya Inc., Avaya Holdings Corp. and Intelsat S.A.
As the Independent Director of Boston Scientific, the total compensation of David Roux at Boston Scientific is $320,203. There are 12 executives at Boston Scientific getting paid more, with Michael Mahoney having the highest compensation of $15,764,100.
David Roux is 63, he's been the Independent Director of Boston Scientific since 2015. There are 4 older and 24 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
David's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 19 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele, and Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: